# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA5040041 | A | Metabolic stability in mouse liver microsomes assessed as half life at 5 uM | Mus musculus | 31 | microsome format | Scientific Literature | ||
2. | ALA5040044 | P | Kinetic aqueous solubility of compound in PBS at pH 7.4 at 250 uM | 32 | small-molecule physicochemical format | Scientific Literature | |||
3. | ALA5040045 | B | Inhibition of NKCC1 in mouse primary hippocampal neurons assessed as reduction of Ca2+ uptake at 10 uM incubated for 15 mins by Fluo-4AM dye based fluorescence analysis relative to control | Mus musculus | 14 | cell-based format | Scientific Literature | ||
4. | ALA5040046 | B | Inhibition of NKCC1 in mouse primary hippocampal neurons assessed as reduction of Ca2+ uptake at 100 uM incubated for 15 mins by Fluo-4AM dye based fluorescence analysis relative to control | Mus musculus | 10 | cell-based format | Scientific Literature | ||
5. | ALA5040047 | A | Stability in mouse plasma assessed as half life at 5 uM | Mus musculus | 13 | cell-free format | Scientific Literature | ||
6. | ALA5040048 | B | Inhibition of KCC2 (unknown origin) transfected in HEK293 cells assessed a reduction in TI influx at 10 uM incubated for 1 hr by fluorescence based analysis relative to control | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
7. | ALA5040049 | B | Inhibition of NKCC1 (unknown origin) transfected in HEK293 cells expressing mbYFPQS plasmid assessed as reduction in Cl- influx at 10 uM incubated for 30 mins by fluorescence multiplate reader analysis | Homo sapiens | 22 | cell-based format | Scientific Literature | ||
8. | ALA5040050 | F | Diuretic activity in wild type mouse assessed as increase in urine volume at 0.6 mg/kg, ip measured after 2 hrs | Mus musculus | 2 | organism-based format | Scientific Literature | ||
9. | ALA5040051 | F | Diuretic activity in Ts65Dn mouse assessed as increase in urine volume at 0.6 mg/kg, ip measured after 2 hrs | Mus musculus | 2 | organism-based format | Scientific Literature | ||
10. | ALA5040052 | F | Cognitive enhancement effect in Ts65Dn mouse assessed as restoration of short-term working memory by measuring number of correct choices at 0.6 mg/kg, ip measured after 1 to 4 weeks by T-maze test | Mus musculus | 1 | organism-based format | Scientific Literature | ||
11. | ALA5040053 | F | Cognitive enhancement effect in Ts65Dn mouse assessed as rescue of poor novel-discrimination ability by measuring increase in time spent in exploring novel object at 0.6 mg/kg, ip measured after 1 to 4 weeks by novel object recognition test | Mus musculus | 1 | organism-based format | Scientific Literature | ||
12. | ALA5040054 | F | Cognitive enhancement effect in Ts65Dn mouse assessed as rescue of electric shock induced freezing response at 0.6 mg/kg, ip measured after 1 to 4 weeks by contextual fear-conditioning test | Mus musculus | 1 | organism-based format | Scientific Literature | ||
13. | ALA5040055 | T | Toxicity in mouse assessed as reduction in body weight at 0.6 mg/kg, ip administered daily for 3 weeks | Mus musculus | 1 | organism-based format | Scientific Literature | ||
14. | ALA5040058 | F | Rescue of hyperactivity in Ts65Dn mouse assessed as assessed as reduction in total distance travelled at 0.6 mg/kg, ip measured after 1 to 4 weeks by open field test | Mus musculus | 1 | organism-based format | Scientific Literature | ||
15. | ALA5040059 | T | Toxicity in Ts65Dn mouse assessed as reduction in body weight at 0.6 mg/kg, ip administered daily for 3 weeks | Mus musculus | 1 | organism-based format | Scientific Literature |